Clinical Trial Update: Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine [NA]

View source ↗

Summary

An update on a clinical trial assessing the immune response in visceral leishmaniasis patients treated with an antimonial drug plus N-acetylcysteine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)
• Sodium stibogluconate (sodium stibogluconate)

Snippet

Sponsor: Hospital Universitário Professor Edgard Santos | Conditions: Visceral Leishmaniasis, Immune Response | NA | Status: UNKNOWN